Back to results
US 2021/0387939 A1Published application
Monomethyl fumarate precursor drug compounds and pharmaceutical compositions thereof
AssigneeAgathonbio Co., Ltd.
InventorsHyung-Chul RYU, Jae-Sun KIM, Jee-Woong LIM, Yeon-Woo SON
Life of this patent
Estimating the term…
Abstract
The present invention provides: novel compounds capable of producing monomethyl fumarate after the compounds are administered; pharmaceutical compositions comprising same as active ingredients; and pharmaceutical uses thereof for treating or alleviating various diseases including immune system abnormalities, neurodegeneration, and/or inflammatory diseases.
Claims7
A compound represented by the following Chemical formula 1.
- In Chemical Formula 1,
- R1, R2, R3 and R4 are each independently selected from the group consisting of hydrogen, —(C1-C3)alkyl, —O—(C1-C3)alkyl, F, Cl, and Br.
(canceled)
Dependencies are inferred from the claim text.